公司資料
Vertex Pharmaceuticals Incorporated 股價、新聞與催化劑
- 股票代碼:
- VRTX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
506.74 USD (-3.07%)
收盤價
最後更新: 2026年10月1日
108B USD
市值
股價為何變動
截至 2026年10月1日，VRTX 下跌 3.07%，收於 $506.74。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Vertex Pharmaceuticals is a global biotechnology company best known for its leadership in cystic fibrosis. The company has expanded beyond CF into gene editing, pain, and other high-value disease areas, making it one of the most important growth stories in biotech.
所在地與產業分類
Vertex is headquartered in the United States and listed on NASDAQ. It has a global commercial footprint and a premium biotech profile.
商業模式特徵
The company generates value from blockbuster product sales, disciplined R&D reinvestment, and a pipeline that extends beyond its core franchise. Investors watch CF execution, pipeline expansion, and whether new programs can preserve growth duration.
生技產業定位
Vertex occupies the top tier of biotechnology because it combines commercial strength with innovation depth. It is less binary than a development-stage stock, but its pipeline still matters a great deal.
未來催化劑
- Vertex's catalysts are ALYFTREK label expansion across the CF franchise and suzetrigine's pain filings and Phase 3 progression. The market will care about whether CF can keep compounding while the pain program turns into a second growth engine, because that is what keeps the long-duration story intact.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。